{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:40:08Z","timestamp":1756662008741,"version":"3.44.0"},"reference-count":28,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"unspecified","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2020,2,9]]},"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Cachexia is common in malignant mesothelioma (MM); half of patients have malnutrition and low skeletal muscle mass. Malnourished patients have worse quality of life (QoL). Weight loss is strongly associated with poor survival. Anamorelin is an oral ghrelin receptor agonist that improves appetite, body weight and QoL in advanced cancer. The aim of this study is to examine the efficacy of anamorelin in improving appendicular skeletal muscle mass (ASM) and patient-reported outcomes in patients with MM with cachexia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>A single-centre, phase II, randomised, placebo-controlled cross-over pilot study with 28-day treatment periods and 3-day washout. Forty patients will be randomised. Primary outcome is change in ASM relative to height measured by dual energy X-ray absorptiometry at end of period 1. Secondary outcomes include cancer-specific and cachexia-related QoL, objective physical activity, dietary intake and adverse events. Eligible patients will have confirmed MM, Eastern Cooperative Oncology Group 0\u20132, expected survival &gt;3 months and cachexia (defined as &gt;5%\u2009weight loss in 6 months or body mass index &lt;20\u2009kg\/m<jats:sup>2<\/jats:sup> with weight loss &gt;2%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>Ethical approval has been granted. Results will be reported in peer-reviewed publications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>Australian New Zealand Clinical Trials Registry (U1111-1240-6828).<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2019-000551","type":"journal-article","created":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T16:15:13Z","timestamp":1585152913000},"page":"e000551","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Randomised placebo-controlled cross-over study examining the role of anamorelin in mesothelioma (The ANTHEM study): rationale and protocol"],"prefix":"10.1136","volume":"7","author":[{"given":"Siao Nge","family":"Hoon","sequence":"first","affiliation":[{"name":"Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia"},{"name":"Curtin Medical School, Curtin University, Perth, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Fyfe","sequence":"additional","affiliation":[{"name":"Curtin Medical School, Curtin University, Perth, Western Australia, Australia"},{"name":"Institute of Respiratory Health, Nedlands, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn J","family":"Peddle-McIntyre","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia"},{"name":"Institute of Respiratory Health, Nedlands, Western Australia, Australia"},{"name":"Exercise Medicine Research Institute, Edith Cowan University\u2014Joondalup Campus, Joondalup, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Bowyer","sequence":"additional","affiliation":[{"name":"Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicity","family":"Hawkins","sequence":"additional","affiliation":[{"name":"Palliative Care, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia"},{"name":"School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Jeffery","sequence":"additional","affiliation":[{"name":"School of Public Health, Curtin University, Perth, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui Jun","family":"Chih","sequence":"additional","affiliation":[{"name":"School of Public Health, Curtin University, Perth, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenette","family":"Creaney","sequence":"additional","affiliation":[{"name":"School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Nowak","sequence":"additional","affiliation":[{"name":"Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia"},{"name":"School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fraser","family":"Brims","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia"},{"name":"Curtin Medical School, Curtin University, Perth, Western Australia, Australia"},{"name":"Institute of Respiratory Health, Nedlands, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,3,25]]},"reference":[{"key":"2025083110142710000_7.1.e000551.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra050152"},{"key":"2025083110142710000_7.1.e000551.2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jtho.2015.12.108","article-title":"A novel clinical prediction model for prognosis in malignant pleural mesothelioma using decision tree analysis","volume":"11","author":"Brims","year":"2016","journal-title":"J Thorac Oncol"},{"key":"2025083110142710000_7.1.e000551.3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.11.136"},{"key":"2025083110142710000_7.1.e000551.4","unstructured":"AIHW . Cancer in Australia 2017. Canberra: Australian Institute of Health and Welfare, 2017."},{"key":"2025083110142710000_7.1.e000551.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67025-0"},{"key":"2025083110142710000_7.1.e000551.6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/bjc.2017.20","article-title":"Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma","volume":"116","author":"Muruganandan","year":"2017","journal-title":"Br J Cancer"},{"key":"2025083110142710000_7.1.e000551.7","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/s41430-019-0418-9","article-title":"Body composition and nutritional status in malignant pleural mesothelioma: implications for activity levels and quality of life","volume":"73","author":"Jeffery","year":"2019","journal-title":"Eur J Clin Nutr"},{"key":"2025083110142710000_7.1.e000551.8","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-3204"},{"key":"2025083110142710000_7.1.e000551.9","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212380"},{"key":"2025083110142710000_7.1.e000551.10","doi-asserted-by":"crossref","unstructured":"Brims F , Lawire I , Qi C , et al . The Relationship of Quality of Life, Physical Symptoms and Survival in Mesothelioma - Exploratory Analyses from the Respect-Meso Study. Am J Respir Crit Care Med 2019:A1247\u2013A47.","DOI":"10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A1247"},{"key":"2025083110142710000_7.1.e000551.11","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v7.i4.17"},{"key":"2025083110142710000_7.1.e000551.12","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.82.6.704"},{"key":"2025083110142710000_7.1.e000551.13","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2015.1041500"},{"key":"2025083110142710000_7.1.e000551.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-012-1500-1"},{"key":"2025083110142710000_7.1.e000551.15","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)71154-4"},{"key":"2025083110142710000_7.1.e000551.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-016-3144-z"},{"key":"2025083110142710000_7.1.e000551.17","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00558-6"},{"key":"2025083110142710000_7.1.e000551.18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.lungcan.2017.07.023","article-title":"Anamorelin for advanced non-small-cell lung cancer with cachexia: systematic review and meta-analysis","volume":"112","author":"Nishie","year":"2017","journal-title":"Lung Cancer"},{"key":"2025083110142710000_7.1.e000551.19","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/cncr.31128","article-title":"Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04)","volume":"124","author":"Katakami","year":"2018","journal-title":"Cancer"},{"key":"2025083110142710000_7.1.e000551.20","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1002\/cncr.32406","article-title":"A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia","volume":"125","author":"Hamauchi","year":"2019","journal-title":"Cancer"},{"key":"2025083110142710000_7.1.e000551.21","unstructured":"McIntyre C . Exercise in Mesothelioma - as part of \" Exercise Training To Improve Care for Patients with Malignant Pleural Disease\" Research Grant:2018\u201320."},{"key":"2025083110142710000_7.1.e000551.22","doi-asserted-by":"crossref","DOI":"10.1186\/s40101-018-0179-5","article-title":"Concordance between appendicular skeletal muscle mass measured with DXA and estimated with mathematical models in middle-aged women","volume":"37","author":"Rathnayake","year":"2018","journal-title":"J Physiol Anthropol"},{"key":"2025083110142710000_7.1.e000551.23","doi-asserted-by":"publisher","DOI":"10.1016\/0169-5002(95)00450-F"},{"key":"2025083110142710000_7.1.e000551.24","first-page":"2341","article-title":"Validation and real-world assessment of the functional assessment of anorexia-cachexia therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS)","volume":"23","author":"LeBlanc","year":"2015","journal-title":"Support Care Cancer"},{"key":"2025083110142710000_7.1.e000551.25","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afy169"},{"key":"2025083110142710000_7.1.e000551.26","first-page":"3261","article-title":"Handgrip strength predicts survival and is associated with markers of clinical and functional outcomes in advanced cancer patients","volume":"21","author":"Kilgour","year":"2013","journal-title":"Support Care Cancer"},{"key":"2025083110142710000_7.1.e000551.27","doi-asserted-by":"publisher","DOI":"10.3148\/74.2.2013.69"},{"key":"2025083110142710000_7.1.e000551.28","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.09.147"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2019-000551","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:14:37Z","timestamp":1756660477000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2019-000551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,3,25]]},"published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10.1136\/bmjresp-2019-000551"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2019-000551","relation":{},"ISSN":["2052-4439"],"issn-type":[{"type":"electronic","value":"2052-4439"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}